---  
layout: startup_page  
title: "Adcendo"  
id: "adcendo.com"  
permalink: "/adcendoadcendo.com11252024/"  
website: "https://www.adcendo.com/"  
funding_round: "Series B"  
funding_amount: "$135M"  
investors: "TCGX, TPG Life Sciences Innovations, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital, Logos Capital, RA Capital Management, Novo Holdings, Pontifax Venture Capital, Dawn Biopharma, KKR, HealthCap, Gilde Healthcare, Ysios Capital"  
about: "Adcendo is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for treating underserved cancers. Their focus is on first-in-class ADCs to address cancers with high unmet medical needs. The company aims to significantly change treatment paradigms through its innovative ADC pipeline."  
markets: "Biotechnology, Oncology, Pharmaceuticals, Biotechnology Research"  
hq: "Frederiksberg, Capital Region of Denmark, Denmark"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/adcendo/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/adcendo"  
pitchbook: "https://pitchbook.com/profiles/company/303080-50"  

date_display: "25-Nov-2024"  
date: "2024-11-25"

# SEO Optimization  
meta_title: "Adcendo - Series B Funding ($135M)"  
meta_description: "Adcendo, Adcendo is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for treating underserved cancers. Their focus is on first..."  
meta_keywords: "Adcendo, Biotechnology, Oncology, Pharmaceuticals, Biotechnology Research, Series B funding"  
canonical_url: "https://startup.projectstartups.com/adcendoadcendo.com11252024/"  
---